STK11 and KEAP1 co-mutated lung adenocarcinoma, which are associated with aggressive tumor growth and immunotherapy resistance (71), had higher repstress scores compared with lung adenocarcinoma without concomitant loss of these genes (Fig. 4M). This evidence concerns the gene KEAP1 and neoplasm.